DE3043981A1 - Verfahren zur gewinnung von fuer interferon in menschlichen zellen kodierender dna, verfahren zur anreicherung von interferon boten-rna (mrna) oder einer induzierbaren mrna eines anderen proteins oder polypeptids, vektoren, verfahren zur abtrennung von mrna eines induzierbaren proteins von anderen mrna's, mrna von menschlichem interferon, in einen vektor einbaubare und fuer ein polypeptid mit interferon-aktivitaet kodierende dna, sowie menschliches interferon (beta)-1 und(beta)-2 in hochgereinigter form - Google Patents

Verfahren zur gewinnung von fuer interferon in menschlichen zellen kodierender dna, verfahren zur anreicherung von interferon boten-rna (mrna) oder einer induzierbaren mrna eines anderen proteins oder polypeptids, vektoren, verfahren zur abtrennung von mrna eines induzierbaren proteins von anderen mrna's, mrna von menschlichem interferon, in einen vektor einbaubare und fuer ein polypeptid mit interferon-aktivitaet kodierende dna, sowie menschliches interferon (beta)-1 und(beta)-2 in hochgereinigter form

Info

Publication number
DE3043981A1
DE3043981A1 DE19803043981 DE3043981A DE3043981A1 DE 3043981 A1 DE3043981 A1 DE 3043981A1 DE 19803043981 DE19803043981 DE 19803043981 DE 3043981 A DE3043981 A DE 3043981A DE 3043981 A1 DE3043981 A1 DE 3043981A1
Authority
DE
Germany
Prior art keywords
interferon
mrna
dna
human
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19803043981
Other languages
German (de)
English (en)
Other versions
DE3043981C2 (enExample
Inventor
Michel Rehovot Revel
Pierre 75013 Paris Tiollais
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Institut Pasteur
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11051449&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3043981(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Institut Pasteur, Yeda Research and Development Co Ltd filed Critical Institut Pasteur
Publication of DE3043981A1 publication Critical patent/DE3043981A1/de
Application granted granted Critical
Publication of DE3043981C2 publication Critical patent/DE3043981C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DE19803043981 1979-11-21 1980-11-21 Verfahren zur gewinnung von fuer interferon in menschlichen zellen kodierender dna, verfahren zur anreicherung von interferon boten-rna (mrna) oder einer induzierbaren mrna eines anderen proteins oder polypeptids, vektoren, verfahren zur abtrennung von mrna eines induzierbaren proteins von anderen mrna's, mrna von menschlichem interferon, in einen vektor einbaubare und fuer ein polypeptid mit interferon-aktivitaet kodierende dna, sowie menschliches interferon (beta)-1 und(beta)-2 in hochgereinigter form Granted DE3043981A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL58765A IL58765A (en) 1979-11-21 1979-11-21 Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta

Publications (2)

Publication Number Publication Date
DE3043981A1 true DE3043981A1 (de) 1981-10-01
DE3043981C2 DE3043981C2 (enExample) 1989-11-30

Family

ID=11051449

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19803043981 Granted DE3043981A1 (de) 1979-11-21 1980-11-21 Verfahren zur gewinnung von fuer interferon in menschlichen zellen kodierender dna, verfahren zur anreicherung von interferon boten-rna (mrna) oder einer induzierbaren mrna eines anderen proteins oder polypeptids, vektoren, verfahren zur abtrennung von mrna eines induzierbaren proteins von anderen mrna's, mrna von menschlichem interferon, in einen vektor einbaubare und fuer ein polypeptid mit interferon-aktivitaet kodierende dna, sowie menschliches interferon (beta)-1 und(beta)-2 in hochgereinigter form
DE3051086A Expired - Lifetime DE3051086C2 (enExample) 1979-11-21 1980-11-21

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE3051086A Expired - Lifetime DE3051086C2 (enExample) 1979-11-21 1980-11-21

Country Status (9)

Country Link
US (4) US5468607A (enExample)
JP (3) JP2555279B2 (enExample)
CH (2) CH684892A5 (enExample)
DE (2) DE3043981A1 (enExample)
FR (1) FR2475901A1 (enExample)
GB (1) GB2063882B (enExample)
IL (1) IL58765A (enExample)
IT (1) IT1194820B (enExample)
SE (2) SE461223C (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0095702A1 (de) * 1982-05-28 1983-12-07 Dr. Karl Thomae GmbH Mikrobiologisch hergestelltes Interferon alpha2(Arg), DNA-Sequenz, die für dieses Interferon codiert, Mikroorganismen, die diese genetische Information enthalten, und Verfahren zu ihrer Herstellung
EP0034307B1 (de) * 1980-02-16 1987-04-08 Hoechst Aktiengesellschaft Verfahren zur Herstellung von menschlichem Leukozyten-Interferon
EP0220574A1 (en) * 1985-10-14 1987-05-06 Yeda Research And Development Company Limited Human interferon beta2A, vectors containing genes coding for said interferon, cell lines producing same
EP0034306B1 (de) * 1980-02-16 1987-05-06 Hoechst Aktiengesellschaft Verfahren zur Herstellung von menschlichem Fibroblasten-Interferon
US5510472A (en) * 1979-11-21 1996-04-23 Yeda Research And Development Co. Ltd. Production of recombinant human interferon-beta2

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56131598A (en) * 1980-03-19 1981-10-15 Japan Found Cancer Novel recombinant plasmid having gene of human fibroblastic interferon messenger rna
US5554513A (en) * 1979-11-21 1996-09-10 Yeda Research & Development Co. Ltd. Production of recombinant human interferon-beta2
DK33181A (da) * 1980-02-06 1981-08-07 Searle & Co Fremgangsmaade til fremstilling af et interferonlignende protein
DE3177213D1 (de) 1980-04-03 1990-10-18 Biogen Inc Dns-sequenzen, rekombinante dns-molekuele und verfahren zur herstellung von dem menschlichen fibroblast-interferon.
EP0042246B1 (en) * 1980-06-12 1987-03-18 The Cancer Institute Of Japanese Foundation For Cancer Research Plasmid
FR2490675B1 (fr) * 1980-09-25 1985-11-15 Genentech Inc Production microbienne d'interferon de fibroplaste humain
US5582824A (en) * 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
US5827694A (en) * 1982-03-08 1998-10-27 Genentech, Inc. DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
US6432677B1 (en) 1982-03-08 2002-08-13 Genentech, Inc. Non-human animal interferons
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US4737462A (en) * 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4966843A (en) * 1982-11-01 1990-10-30 Cetus Corporation Expression of interferon genes in Chinese hamster ovary cells
US5831023A (en) * 1982-11-01 1998-11-03 Genentech, Inc. Recombinant animal interferon polypeptides
US4855238A (en) 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
EP0569687B1 (en) * 1984-05-18 2002-08-21 New England Medical Center Hospitals, Inc. Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins
US5998578A (en) * 1984-05-18 1999-12-07 New England Medical Center Hospitals, Inc. Biologically active fragments of IL-1β
US5122459A (en) * 1984-12-31 1992-06-16 Immunex Corporation Gene encoding biologically active human interleukin 1
FI865253A0 (fi) * 1985-04-23 1986-12-22 Medical Biology Inst Identifiering av ige-bindningsprotein med hjaelp av molekylkloning.
DE3683186D1 (de) 1985-04-25 1992-02-13 Hoffmann La Roche Rekombinantes humaninterleukin-1.
US5425940A (en) * 1986-04-09 1995-06-20 Cetus Oncology Corporation Combination therapy using interleukin-2 and tumor necrosis factor
US6284237B1 (en) 1986-07-08 2001-09-04 Steven C. Clark Methods of treatment using IL-6
IE67035B1 (en) * 1986-07-08 1996-02-21 Genetics Inst Production and use of non-glycosylated IL-6
EP0257406B2 (en) * 1986-08-06 1998-08-12 Ajinomoto Co., Inc. Recombinant B-cell differentiation factor
US4939093A (en) * 1987-02-02 1990-07-03 Cetus Corporation Human IL-2 like polypeptides, DNA sequences and recombinant DNA molecules therefore and methods for the production and use thereof
US4961969A (en) * 1987-05-11 1990-10-09 Cetus Corporation Process for recovering microbially produced interferon-β
IL88375A (en) * 1988-11-14 1995-07-31 Yeda Res & Dev Monoclonal antibodies that specifically bind interferon-bia 2 natural and recombinant and a natural and recombinant interferon-beta 2 purification method and method
US5338834A (en) * 1993-01-26 1994-08-16 Allelix Biopharmaceuticals Inc. Ultrapure human interleukin-6
US20050002902A1 (en) * 1995-12-28 2005-01-06 Liming Yu Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections
US20030026779A1 (en) * 1999-10-15 2003-02-06 Liming Yu Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
RU2318829C2 (ru) * 2001-11-14 2008-03-10 Сентокор, Инк. Антитела против il-6, композиции, способы и применение
US20050100550A1 (en) * 2003-11-10 2005-05-12 Mohit Trikha Anti-angiogenic uses of IL-6 antagonists
CN103755800B (zh) 2004-02-02 2016-02-24 Ambrx公司 经修饰的人类生长激素多肽与其用途
PA8672101A1 (es) * 2005-04-29 2006-12-07 Centocor Inc Anticuerpos anti-il-6, composiciones, métodos y usos
US9701747B2 (en) 2007-05-21 2017-07-11 Alderbio Holdings Llc Method of improving patient survivability and quality of life by anti-IL-6 antibody administration
US8062864B2 (en) 2007-05-21 2011-11-22 Alderbio Holdings Llc Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies
US8404235B2 (en) * 2007-05-21 2013-03-26 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US7906117B2 (en) * 2007-05-21 2011-03-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
US8178101B2 (en) 2007-05-21 2012-05-15 Alderbio Holdings Inc. Use of anti-IL-6 antibodies having specific binding properties to treat cachexia
CN101754772B (zh) 2007-05-21 2015-08-19 奥尔德生物控股有限责任公司 针对il-6的抗体及其用途
US8252286B2 (en) 2007-05-21 2012-08-28 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US20090238825A1 (en) * 2007-05-21 2009-09-24 Kovacevich Brian R Novel rabbit antibody humanization methods and humanized rabbit antibodies
KR20100028571A (ko) * 2007-05-21 2010-03-12 앨더 바이오파마슈티컬즈, 인코포레이티드 신규한 래빗 항체 인간화 방법 및 인간화된 래빗 항체
NZ602170A (en) 2008-02-08 2014-03-28 Ambrx Inc Modified leptin polypeptides and their uses
US8777182B2 (en) 2008-05-20 2014-07-15 Grinon Industries Fluid transfer assembly and methods of fluid transfer
US8188235B2 (en) * 2008-06-18 2012-05-29 Pfizer Inc. Antibodies to IL-6 and their uses
US8992920B2 (en) 2008-11-25 2015-03-31 Alderbio Holdings Llc Anti-IL-6 antibodies for the treatment of arthritis
US9452227B2 (en) 2008-11-25 2016-09-27 Alderbio Holdings Llc Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
US8420089B2 (en) 2008-11-25 2013-04-16 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US8323649B2 (en) 2008-11-25 2012-12-04 Alderbio Holdings Llc Antibodies to IL-6 and use thereof
US9212223B2 (en) 2008-11-25 2015-12-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US8337847B2 (en) 2008-11-25 2012-12-25 Alderbio Holdings Llc Methods of treating anemia using anti-IL-6 antibodies
US9775921B2 (en) 2009-11-24 2017-10-03 Alderbio Holdings Llc Subcutaneously administrable composition containing anti-IL-6 antibody
EP2504032A4 (en) 2009-11-24 2013-06-19 Alderbio Holdings Llc IL-6 ANTAGONISTS FOR PREVENTING OR TREATING THROMBOSIS
CA2818814A1 (en) 2010-11-23 2012-05-31 Alder Biopharmaceuticals, Inc. Anti-il-6 antibodies for the treatment of anemia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
FR2321298A1 (fr) * 1975-08-01 1977-03-18 Anvar Procede de preparation de produits a activite interferon
NZ187300A (en) * 1977-05-27 1982-08-17 Univ California Dna transfer vector and micro-organism modified to contain a nucleotide sequence equivalent to the gene of a higher organism
US5326859A (en) * 1979-10-30 1994-07-05 Juridical Foundation, Japanese Foundation For Cancer Research DNA and recombinant plasmid
JPS5663996A (en) * 1979-10-30 1981-05-30 Japan Found Cancer Novel recombinant having gene complementary to human interferon messenger rna
FI77877C (fi) * 1979-04-20 1989-05-10 Technobiotic Ltd Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
US4262090A (en) * 1979-06-04 1981-04-14 Cetus Corporation Interferon production
US4289689A (en) * 1980-03-14 1981-09-15 Hoffmann-La Roche Inc. Preparation of homogeneous human fibroblast interferon
JPS5655731A (en) * 1979-10-11 1981-05-16 Ogura Clutch Co Ltd Clutch/brake device
NL7907791A (nl) * 1979-10-23 1981-04-27 Stichting Rega V Z W Werkwijze voor het zuiveren van interferon.
DE3177213D1 (de) * 1980-04-03 1990-10-18 Biogen Inc Dns-sequenzen, rekombinante dns-molekuele und verfahren zur herstellung von dem menschlichen fibroblast-interferon.
FI811009L (fi) * 1980-06-06 1981-12-07 Biogen Nv Foerbaettrade vektorer foerfaranden foer framstaellning av dessa vektorer och foer expression av klonade gener

Non-Patent Citations (15)

* Cited by examiner, † Cited by third party
Title
Ann. N.Y. Sci. 173, 1970, 390-403 *
Antimicrob. Ag. Chemother., 2, 1972, 476-484 *
CA 106 454v, Vol. 91, Sept. 17, 1979
Cell 16, S.443 ff, 1979 *
Genetic Engineering, Bd. 1, 1979, 15 ff *
J. Biol. Chem., 253, 1978, 2471 ff *
J. Gen. Virol., 19, 1973, 1-8 *
J. Mol. Biol. 129, S.19 ff, 1979 *
J.gen.Virol.19 (1973), S.1-8
J.Mol.Biol. (1979), 129, S.19-35
Nature Vol.288, S.95-97, 6.Nov.1980
Nature, Vol. 222, 1969, 682-683 *
Nature, Vol. 288, 06.11.80, S. 95-97
Nugl. Acids Res., 4, 1977, 3455 ff *
Pharmazie in unserer Zeit, 1979, Nr.4, S. 113-118

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510472A (en) * 1979-11-21 1996-04-23 Yeda Research And Development Co. Ltd. Production of recombinant human interferon-beta2
EP0034307B1 (de) * 1980-02-16 1987-04-08 Hoechst Aktiengesellschaft Verfahren zur Herstellung von menschlichem Leukozyten-Interferon
EP0034306B1 (de) * 1980-02-16 1987-05-06 Hoechst Aktiengesellschaft Verfahren zur Herstellung von menschlichem Fibroblasten-Interferon
EP0095702A1 (de) * 1982-05-28 1983-12-07 Dr. Karl Thomae GmbH Mikrobiologisch hergestelltes Interferon alpha2(Arg), DNA-Sequenz, die für dieses Interferon codiert, Mikroorganismen, die diese genetische Information enthalten, und Verfahren zu ihrer Herstellung
EP0220574A1 (en) * 1985-10-14 1987-05-06 Yeda Research And Development Company Limited Human interferon beta2A, vectors containing genes coding for said interferon, cell lines producing same

Also Published As

Publication number Publication date
SE461223B (sv) 1990-01-22
JPS63164896A (ja) 1988-07-08
SE461223C (sv) 1997-02-02
IL58765A (en) 1986-09-30
IT1194820B (it) 1988-09-28
US5468609A (en) 1995-11-21
US5468608A (en) 1995-11-21
SE469660B (sv) 1993-08-16
US5468607A (en) 1995-11-21
FR2475901B1 (enExample) 1985-02-15
GB2063882B (en) 1984-05-31
SE8007998L (sv) 1981-05-22
JP2548201B2 (ja) 1996-10-30
DE3043981C2 (enExample) 1989-11-30
JPS5685296A (en) 1981-07-11
JPH02211879A (ja) 1990-08-23
CH664967A5 (de) 1988-04-15
DE3051086C2 (enExample) 1992-11-05
US5541312A (en) 1996-07-30
SE8603145L (sv) 1986-07-17
CH684892A5 (de) 1995-01-31
IT8026172A0 (it) 1980-11-21
SE8603145D0 (sv) 1986-07-17
IL58765A0 (en) 1980-02-29
JP2555279B2 (ja) 1996-11-20
FR2475901A1 (fr) 1981-08-21
GB2063882A (en) 1981-06-10

Similar Documents

Publication Publication Date Title
DE3043981C2 (enExample)
DE3177288T2 (de) Reife menschliche leukozyten-interferone, verfahren zu ihrer bacteriellen herstellung, zwischenprodukte hierfuer und zusammensetzungen diese enthaltend.
DE3238554C2 (enExample)
DE3382742T2 (de) Ein Consensus-Leukozyten-Interferon und ein dafür kodierendes Gen.
DE3588168T2 (de) Apoaequorin Peptide, rekombinante DNS-Vektoren fähig zu deren Expression und diese Vektoren enthaltende Mikroorganismen
DE3546806C2 (enExample)
DE3750451T2 (de) Rekombinanter menschlicher endothelzellenwachstumsfaktor.
DD203330A5 (de) Verfahren zur herstellung hybrider human-leukozyten-interferone
CH660743A5 (de) Hybride human-leukozyten-interferone und deren mikrobielle herstellung.
DE3220116C2 (enExample)
DD159782A5 (de) Verfahren zur herstellung eines eine immunologische oder biologische aktivitaet von humanleukozyten-interferon aufweisendes polypeptids
DD204494A5 (de) Verfahren zum schneiden doppelstraengiger dns
EP0099084A2 (de) Verfahren zur Herstellung von Interferon und Expressionsvektoren dafür
DD209652A5 (de) Verfahren zur herstellung eines replikablen vektors
DE3586972T2 (de) Gereinigtes interleukin-1.
DD154022A5 (de) Verfahren zur herstellung von menschlichem pre-wachstumshormon
DE3588241T2 (de) Menschliche IL-1 cDNS-Sequenzen die für biologisch aktive menschliche IL-1-Proteine kodieren
AT394209B (de) Verfahren zur herstellung neuer mikroorganismen zur produktion von hybriden human-leukozyten-interferonen
DE3103714A1 (de) Dns-rekombinationsverfahren zur herstellung eines dem menschlichen interferon aehnlichen proteins
DE69303685T2 (de) Verfahren zur Expression von Rezeptoren des menschlichen Nervensystems in der Hefe Schizosaccharomyces Pombe
AT392082B (de) Das polypeptid interleukin-2 kodierendes gen, rekombinante, dieses gen enthaltende dna, diese rekombinante dna aufweisende zellinien und verfahren zur herstellung von interleukin-2 unter verwendung der genannten zellen
CH685299A5 (de) Menschliches Fibroblasteninterferon beta 2, Verfahren zur Herstellung von menschlichem Fibroblasteninterferon beta 1 und beta 2 und deren Verwendung.
AT394208B (de) Verfahren zur herstelluung von vektoren
AT394207B (de) Verfahren zur herstellung von human-leukozyteninterferonen
Bloemendal et al. Organization and expression of the vimentin gene

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8127 New person/name/address of the applicant

Owner name: YEDA RESEARCH AND DEVELOPMENT CO., LTD., REHOVOT,

8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 3051086

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 3051086

8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 3051180

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 3051180

8128 New person/name/address of the agent

Representative=s name: GRUENECKER, A., DIPL.-ING. KINKELDEY, H., DIPL.-IN

AH Division in

Ref country code: DE

Ref document number: 3051180

Format of ref document f/p: P

Ref country code: DE

Ref document number: 3051086

Format of ref document f/p: P

D2 Grant after examination
8363 Opposition against the patent
8330 Complete renunciation
AH Division in

Ref country code: DE

Ref document number: 3051086

Format of ref document f/p: P